The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development.
Saved in:
| Title: | The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development. |
|---|---|
| Authors: | Vyse A; Pfizer Ltd, Walton Oaks, Tadworth KT20 7NS, UK., Campling J; Pfizer Ltd, Walton Oaks, Tadworth KT20 7NS, UK., Czudek C; Pfizer Ltd, Walton Oaks, Tadworth KT20 7NS, UK., Ellsbury G; Pfizer Ltd, Walton Oaks, Tadworth KT20 7NS, UK., Slack M; School of Medicine, Griffith University, Gold Coast Campus, Queensland 4222, Australia. |
| Source: | Vaccine [Vaccine] 2020 Dec 03; Vol. 38 (51), pp. 8068-8070. Date of Electronic Publication: 2020 Nov 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1873-2518 |
|---|---|
| DOI: | 10.1016/j.vaccine.2020.10.090 |
